Mangalore Doctors Report Rare Case Of Corneal Bee Sting In NEJM
- byDoctor News Daily Team
- 17 July, 2025
- 0 Comments
- 0 Mins
Dr Teena M. Mendonca and Dr Gladys R. Rodrigues at Kasturba Medical College Mangalore, Mangalore, India have reported a rare case of corneal bee sting so which has appeared in New England journal of Medicine.
Bee sting injury to the cornea is a rare occurrence with a sequelae ranging from mild conjunctival hyperemia to intractable secondary glaucoma. It is an uncommon environmental eye injury that can result in various ocular complications with an etiology of penetrating, immunologic, and toxic effects of the stinger and its injected venom.It is seen mostly during gardening, farm work and bike ride, without eye protection. Bee and wasp belong to Hymenoptera species of insects. Bee venom is a mixture of toxic substances such as Phospholipase A, Phospholipase B, Apamine, Hyalouronidase, Mast cell degranulating peptide and Mastoparan peptide. The venom is injected in the tissue and aqueous humour. These toxins are responsible for acute reaction in the eye.
According to the history , a 22-year-old man presented to the emergency department with redness, pain, and decreased vision 1 hour after being stung by a bee in the left eye. The visual acuity in the right eye was 20/20, but the patient reported seeing only hand movements close to his face with the left eye. Ocular examination of the left eye showed diffuse corneal haziness caused by corneal edema; a retained stinger that was surrounded by infiltrates was visible (arrow). Corneal bee stings, although rare, can have manifestations ranging from mild irritation to vision loss. Possible complications include corneal decompensation and secondary glaucoma. The patient was treated with a moxifloxacin ophthalmic solution, and the stinger was removed under local anesthesia. The corneal wound was secured with sutures after thorough cleansing of the anterior chamber. The patient was prescribed a 2-week course of topical glucocorticoids, antibiotics, and cycloplegic medications. At the 3-month follow-up, the corneal edema had resolved and the visual acuity was 20/40 in the left eye.
For further reference log on to:DOI: 10.1056/NEJMicm2024132
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Eli Lilly plans to build new USD 3 billion facilit...
- 04 November, 2025
Rajkot Maternity Hospital CCTV Leak: How a simple...
- 04 November, 2025
Gland Pharma profit rises 12 percent to Rs 184 cro...
- 04 November, 2025
AIIMS Delhi doctors told to use Hindi in prescript...
- 04 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!